FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmaceutical industry and concerns composition and method of producing the preparation of highly effective pharmaceutical substance and excipients allowing to form a fine particle aerosol to penetrate into the bronchi and pulmonary alveoli. Inhalation formulation for treating bronchial asthma and chronic obstructive pulmonary disease, containing as active component fenoterol hydrobromide, as a solvent-pure ethyl alcohol, a propellant, the propellant contains HFA-134a and/or HFA-227ea, as well as additionally contains an acidity regulator selected from hydrochloric acid, phosphoric and citric acids, as a substance which regulates the distribution profile, triethyl citrate.
EFFECT: invention provides higher respirable fraction up to 35-40 % and obtaining optimum distribution profile of particles.
2 cl, 1 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
COMBINED AEROSOL PREPARATION FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2536253C1 |
AEROSOL PREPARATION OF IPRATROPIUM BROMIDE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2519653C1 |
INHALATION FORMULATION IN FORM OF AEROSOL FOR TREATING BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2504402C1 |
AEROSOL COMBINATION OF SALMETEROL AND FLUTICASONE FOR TREATING RESPIRATORY DISEASES | 2013 |
|
RU2521975C1 |
STABLE SOLUTION OF FENOTEROL HYDROBROMIDE | 2012 |
|
RU2479304C1 |
STABLE COMBINED SOLUTION OF FENOTEROL HYDROBROMIDE AND IPRATROPIUM BROMIDE | 2012 |
|
RU2493827C1 |
PHARMACEUTICAL COMPOSITION OF METERED AEROSOLS CONTAINING ANTIASTHMATIC AGENTS IN FORM OF SUSPENSIONS, SOLUTIONS, EMULSIONS, SOLUTIONS AND EMULSIONS | 2007 |
|
RU2356537C2 |
METHOD AND SYSTEM FOR MDI ELECTRONIC MODEL (DOSING INHALANT DEVICE) | 2012 |
|
RU2633269C2 |
AEROSOL PREPARATION ADAPTED TO BE APPLIED IN SEALED AEROSOL-TYPE CONTAINER | 1999 |
|
RU2214230C2 |
PHARMACEUTICAL COMPOSITIONS CONTAINING RPL554 IN HFA-134A FOR ADMINISTRATION BY INHALATION | 2019 |
|
RU2813959C2 |
Authors
Dates
2016-03-10—Published
2015-03-26—Filed